Related Experiment Video
Updated: Jan 23, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease
Shan Tong1,2, Qingwei Ji3, Yu Du1
11Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.
Abstract:
Adipose tissue stores energy and is the largest endocrine organ in the body, producing several adipokines. However, among these adipokines, few play a role in the positive metabolism that promotes good health. Secreted frizzled-related protein (Sfrp)-5, an antagonist that directly binds to Wnt, has attracted interest due to its favorable effects on atherosclerotic cardiovascular disease (ASCVD). This review focuses on Sfrp5 biology and the roles of the Sfrp5/Wnt system in ASCVD.
Insights
Secreted frizzled-related protein-5 (Sfrp5) shows promise for improving metabolic health and combating atherosclerotic cardiovascular disease (ASCVD). This review explores Sfrp5 biology and its role in the Sfrp5/Wnt system
Area of Science:
- Endocrinology
- Metabolic research
- Cardiovascular science
Background:
- Adipose tissue is a major endocrine organ producing adipokines.
- Few adipokines promote positive metabolism and good health.
- Secreted frizzled-related protein-5 (Sfrp5) is an emerging adipokine with potential health benefits.
Purpose of the Study:
- To review the biology of Sfrp5.
- To examine the role of the Sfrp5/Wnt system in atherosclerotic cardiovascular disease (ASCVD).
Main Methods:
- Literature review of Sfrp5 biology.
- Analysis of Sfrp5/Wnt signaling pathways.
- Examination of Sfrp5's impact on ASCVD.
Main Results:
- Sfrp5 acts as a Wnt antagonist.
- Sfrp5 exhibits favorable effects on ASCVD.
- The Sfrp5/Wnt system is implicated in cardiovascular health.
Conclusions:
- Sfrp5 is a significant factor in metabolic regulation.
- Targeting the Sfrp5/Wnt pathway may offer therapeutic strategies for ASCVD.
- Further research into Sfrp5's functions is warranted.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cis-regulatory Sequences
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

